Catalyst Pharmaceuticals Inc.

NASDAQ: CPRX
Share price (10/2/25): $20.84
Market cap (10/2/25): $2.551 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Additional exhibits for registration

Additional exhibits for registration

Additional exhibits for registration

Prospectus supplement for primary offering

Ownership Filter

News Filter

Announces $200 Million Share Repurchase Program

UPDATED: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (Amifampridine) Patent Litigation With Lupin Pharmaceuticals

Announces Settlement of FIRDAPSE® (Amifampridine) Patent Litigation With Lupin Pharmaceuticals

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer

Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC